The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Increasing the Age at Onset for ADHD?

To the Editor: In their commentary, published in the January 2010 issue of the Journal, Christian Kieling, M.D., et al. (1) presented the rationale for a DSM–5 proposal to increase the required age at onset for attention deficit hyperactivity disorder (ADHD) from age 7 years to 12 years. Unfortunately, the commentary did not include a risk/benefit analysis. The authors focus only on the benefit of reducing false negatives and ignore the considerable risk that eliminating this age of onset gatekeeper will result in a flood of new false positives for a diagnosis that may already be quite overinclusive.

Especially in adolescents and adults, real or perceived attention problems are so common and so nonspecific that ADHD can be easily overdiagnosed in those suffering from any number of other mental disorders and in those who are merely seeking performance enhancement (26).

Coronado, Calif.

The author receives royalties from American Psychiatric Publishing for a DSM–IV guidelines book.

References

1 Kieling C , Kieling RR , Rohde LA , Frick PJ , Moffitt T , Nigg JT , Tannock R , Castellanos FX : The age at onset of attention deficit hyperactivity disorder. Am J Psychiatry 2010; 167:14–15 LinkGoogle Scholar

Visser S , Lesesne C : Mental health in the United States: prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder: United States, 2003. JAMA 2005; 294:2293–2296 CrossrefGoogle Scholar

3 Faraone S , Sergeant J , Gillberg C , Biederman J : The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2003; 2:104–113 MedlineGoogle Scholar

4 Olfson M , Gameroff M , Marcus S , Jensen P : National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2003; 160:1071–1077 LinkGoogle Scholar

5 Bogle K , Smith B : Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Curr Drug Abuse Rev 2009; 2:157–176 Crossref, MedlineGoogle Scholar

6 Wilens T , Adler L , Adams J , Sgambati S , Rotrosen J , Sawtelle R , Utzinger L , Fusillo S : Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008; 47:21–31 Crossref, MedlineGoogle Scholar